These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8818851)

  • 1. A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections.
    Zachariah J
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():103-13. PubMed ID: 8818851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
    Gris P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
    Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
    Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections.
    Ferwerda A; Moll HA; Hop WC; Kouwenberg JM; Tjon Pian Gi CV; Robben SG; de Groot R
    J Antimicrob Chemother; 2001 Apr; 47(4):441-6. PubMed ID: 11266417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
    Hoepelman AI; Sips AP; van Helmond JL; van Barneveld PW; Neve AJ; Zwinkels M; Rozenberg-Arska M; Verhoef J
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():147-52. PubMed ID: 8396086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group.
    Biebuyck XA
    J Int Med Res; 1996; 24(5):407-18. PubMed ID: 8895044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open, multicentre, comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. The Paediatric Azithromycin Study Group.
    Lauvau DV; Verbist L
    J Int Med Res; 1997; 25(5):285-95. PubMed ID: 9364291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults.
    Clement PA; de Gandt JB
    J Int Med Res; 1998; 26(2):66-75. PubMed ID: 9602984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
    Dunne MW; Latiolais T; Lewis B; Pistorius B; Bottenfield G; Moore WH; Garrett A; Stewart TD; Aoki J; Spiegel C; Boettger D; Shemer A
    J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children.
    Schaad UB
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():81-8. PubMed ID: 8396101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections.
    Laurent K
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():115-24. PubMed ID: 8818852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, open label trial of azithromycin vs. amoxicillin/ clavulanate for the management of acute otitis media in children.
    Aronovitz G
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S15-9. PubMed ID: 8878241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children.
    Daniel RR
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():65-71. PubMed ID: 8396099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy, safety and tolerability of azithromycin and co-amoxiclav in the treatment of acute periapical abscesses.
    Adriaenssen CF
    J Int Med Res; 1998; 26(5):257-65. PubMed ID: 9924711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
    Cazzola M; Vinciguerra A; Beghi GF; Paizis G; Giura R; Madonini V; Fiorentini F; Consigli GF; Tonna M; Casalini A
    J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women.
    Masterton RG; Bochsler JA
    J Antimicrob Chemother; 1995 Jan; 35(1):129-37. PubMed ID: 7768760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis.
    De Abate CA; Perrotta RJ; Dennington ML; Ziering RM
    J Chemother; 1992 Dec; 4(6):358-63. PubMed ID: 1287138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical and economic efficacies of short courses of azithromycin in acute sinusitis].
    Karpov OI
    Antibiot Khimioter; 1999; 44(10):28-32. PubMed ID: 10635419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media.
    Arrieta A; Arguedas A; Fernandez P; Block SL; Emperanza P; Vargas SL; Erhardt WA; de Caprariis PJ; Rothermel CD
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3179-86. PubMed ID: 14506028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis.
    Beghi G; Berni F; Carratù L; Casalini A; Consigli G; D'Antò M; Gioia V; Molino A; Paizis G; Vaghi A
    J Chemother; 1995 Apr; 7(2):146-52. PubMed ID: 7666122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.